Helmholtz Zentrum München
32
6
8
20
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 32 trials
100.0%
+13.5% vs industry average
9%
3 trials in Phase 3/4
0%
0 of 20 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (32)
Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
Role: collaborator
Anti-viral Action Against Type 1 Diabetes Autoimmunity
Role: collaborator
A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate
Role: collaborator
Adipositas Care & Health Therapy
Role: collaborator
Monitoring COVID-19 Vaccination Response in Fragile Populations
Role: collaborator
A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis
Role: collaborator
Freder1k-Study - Testing Infants for Type 1 Diabetes Risk
Role: lead
Fr1da Early Diagnosis and Care of Type 1 Diabetes
Role: lead
Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity
Role: lead
Fr1da Insulin Intervention
Role: collaborator
GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)
Role: collaborator
Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control (DIA-LINK Study)
Role: collaborator
Economic Aspects of Extreme Obesity in Adolescent
Role: collaborator
Course of Obesity and Extreme Obesity in Adolescents
Role: collaborator
Study on Infectious Mononucleosis in Munich
Role: collaborator
Early Versus Emergency Left Ventricular Assist Device Implantation in Patients Awaiting Cardiac Transplantation
Role: collaborator
Evaluation of a Stepped Care Approach to Manage Depression in Diabetes
Role: collaborator
Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control in T2DM
Role: collaborator
The Munich Adrenaline Cancer Study
Role: collaborator
PINIT Study: Primary Intranasal Insulin Trial
Role: collaborator